New advances in the treatment of Sarcoma

dc.contributor.advisorPórszász, Róbert
dc.contributor.advisordeptDebreceni Egyetem::Általános Orvostudományi Kar::Farmakológiai és Farmakoterápiai Intézethu_HU
dc.contributor.authorGal, Ido
dc.contributor.departmentDE--Általános Orvostudományi Karhu_HU
dc.contributor.opponentDrimba, László
dc.contributor.opponentSzentmiklósi, József András
dc.contributor.opponentdeptKenézy Kórház, Aneszteziológiai és Intenziv Therápiás Osztályhu_HU
dc.contributor.opponentdeptDebreceni Egyetem::Általános Orvostudományi Kar::Farmakológiai és Farmakoterápiai Intézethu_HU
dc.date.accessioned2022-01-27T10:02:17Z
dc.date.available2022-01-27T10:02:17Z
dc.date.created2020-12-21
dc.description.abstractThe focus of this paper is to cover the evolution in the pharmacologic approach in the treatment of sarcoma. As early as conservative treatment all the way through recent advances and other promising treatments which are under investigation. Nowadays, no universal approach had been adopted in the treatment of sarcoma creating an urge to investigate potential agents improving the overall prognosis of the chaotic malignancy. Surgery and radiotherapy remain an integral part of therapy and are routinely used in the treatment of sarcomas, the pharmacologic approach is based on chemotherapy with an emphasis of agents such as cytotoxins, targeted epigenetic, immune therapy, checkpoints inhibitors, adoptive immunity.hu_HU
dc.description.courseáltalános orvoshu_HU
dc.description.courselangangolhu_HU
dc.description.degreeegységes, osztatlanhu_HU
dc.format.extent45hu_HU
dc.identifier.urihttp://hdl.handle.net/2437/328223
dc.language.isoenhu_HU
dc.language.isoegyébhu_HU
dc.subjectsarcomahu_HU
dc.subjectsarcoma treatmenthu_HU
dc.subjectsarcoma pharmacologic interventionhu_HU
dc.subjectadvanced approach to sarcomahu_HU
dc.subjectsarcoma epigeneticshu_HU
dc.subject.dspaceDEENK Témalista::Orvostudományhu_HU
dc.titleNew advances in the treatment of Sarcomahu_HU
Fájlok